AI diet coach takes on fatty liver: 216-Person trial launches

NCT ID NCT07497750

Not yet recruiting Disease control Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence (AI) program that gives personalized diet and exercise advice can help people with non-alcoholic fatty liver disease (NAFLD) reduce liver fat more than standard lifestyle counseling. About 216 adults with NAFLD and overweight will be randomly assigned to either the AI-driven program or usual care for 12 months. The main goal is to see if more people in the AI group achieve at least a 30% drop in liver fat measured by MRI.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE

Contacts and locations

Locations

APHP Cochin

Paris, 75014, France
APHP Hôpital Beaujon

Clichy, 92110, France
CHU Angers

Angers, 49933, France
CHU Bordeaux

Pessac, 33600, France
CHU Dijon Hôpital Le Bocage

Dijon, 21000, France
CHU Lyon

Lyon, 69310, France
CHU Nantes

Nantes, 44093, France
CHU Toulouse Rangueil

Toulouse, 31059, France
Clinique Pasteur Toulouse

Toulouse, 31300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.